# The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis

> **NCT07250854** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 15 (estimated)

## Conditions studied

- Biliary Atresia
- Kasai
- Cholestasis in Newborn
- Cholestasis in Newborn Infant

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT07250854
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-23
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07250854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07250854, "The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07250854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*